Hims & Hers Health’s third quarter results prompted a positive market reaction as the company delivered strong revenue growth ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Shares of Hims & Hers Health ($HIMS) rallied on Tuesday after management said it’s in discussions with Novo Nordisk ($NVO) to ...

Less than six months after ending a short-lived partnership, US telehealth firm Hims & Hers (Nasdaq: HIMS) and Danish ...

Global populations are aging, a reality that is leading to increased demand for healthcare services, chronic disease ...

Virtual healthcare platforms are redefining patient access to care, with Hims & Hers Health, Inc. HIMS and LifeMD, Inc. LFMD ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Hims & Hers Health, Inc. HIMS is scheduled to report third-quarter 2025 results on Nov. 3, after the closing bell. In the ...

Hims & Hers posted record revenue this quarter. It is still selling patented weight loss drugs on its platform and is now getting sued by the pharmaceutical companies. Investors would do best to avoid ...

In a surprising turn of events, Hims and Hers Health has reported a third-quarter profit that fell short of Wall Street expectations. The company, which has gained popularity for its telehealth ...

HIMZ offers 2x leveraged exposure to HIMS, ideal for high-risk, short-term traders seeking amplified volatility, not long-term investors. Recent HIMS volatility, including the Novo Nordisk partnership ...